Suppr超能文献

在 pT3a 肾细胞癌中,肝门静脉内脂肪浸润和肿瘤扩展的预后价值。

The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma.

机构信息

Department of Urology, University of Tuebingen, Tübingen, Germany.

Department of Pathology, University of Tuebingen, Tübingen, Germany.

出版信息

World J Urol. 2021 Sep;39(9):3367-3376. doi: 10.1007/s00345-021-03638-0. Epub 2021 Feb 27.

Abstract

PURPOSE

The 7th TNM classification summarizes renal cell carcinoma (RCC) with perirenal (PFI) and/or sinus fat invasion (SFI) as well as hilar vein involvement (RVI) as pT3a tumors. In this study, we aimed to determine the prognostic value of fat invasion (FI) in the different compartments and RVI for medium-term cancer-specific-survival (CSS) in pT3a RCC.

MATERIALS AND METHODS

Patients with pT3a RCC were identified using an institutional database. All original pathological reports were reclassified according to the 7th TNM edition. The prognostic value of FI as well as divided into PFI, SFI, combined PFI + SFI, and RVI for CSS was assessed using univariate and multivariate Cox-regression analysis. Survival was estimated using the Kaplan-Meier method.

RESULTS

Median follow-up in 184 pT3a tumors was 38 months. FI was detectable in 153 patients (32.7% PFI, 45.1% SFI, 22.2% PFI + SFI), 31 patients showed RVI alone. Combined PFI + SFI increased the risk of cancer-related death compared to PFI (HR 3.11, p < 0.01), SFI (HR 1.84, p = 0.023) or sole RVI (HR 2.12, p = 0.025). In multivariate analysis, a combined PFI + SFI vs. PFI or SFI as the only compartment involved was confirmed as independent prognostic factor (HR 1.83, p = 0.029). Patients with FI and simultaneous RVI had significantly shorter CSS (HR 2.63, p < 0.01). In an unweighted model, the difference between patients with combined PFI + SFI and RVI and those with PFI alone was highest (HR 4.01, p = 0.029).

CONCLUSIONS

These results underline the subdivision of pT3a RCC depending on the location of FI and RVI for patient stratification.

摘要

目的

第 7 版 TNM 分类将肾细胞癌(RCC)的肾周(PFI)和/或窦脂肪浸润(SFI)以及肝静脉受累(RVI)归类为 pT3a 肿瘤。本研究旨在确定不同部位脂肪浸润(FI)和 RVI 对 pT3a RCC 中期癌症特异性生存(CSS)的预后价值。

材料和方法

使用机构数据库确定 pT3a RCC 患者。根据第 7 版 TNM 分期对所有原始病理报告进行重新分类。使用单变量和多变量 Cox 回归分析评估 FI 以及分为 PFI、SFI、PFI+SFI 合并和 RVI 对 CSS 的预后价值。使用 Kaplan-Meier 方法估计生存情况。

结果

184 例 pT3a 肿瘤的中位随访时间为 38 个月。153 例患者(32.7% PFI、45.1% SFI、22.2% PFI+SFI)可检测到 FI,31 例患者仅显示 RVI。与 PFI(HR 3.11,p<0.01)、SFI(HR 1.84,p=0.023)或单独的 RVI(HR 2.12,p=0.025)相比,PFI+SFI 合并增加了癌症相关死亡的风险。在多变量分析中,PFI+SFI 合并与 PFI 或 SFI 作为唯一受累部位相比,被证实为独立的预后因素(HR 1.83,p=0.029)。FI 合并同时有 RVI 的患者 CSS 显著缩短(HR 2.63,p<0.01)。在未加权模型中,PFI+SFI 合并与 RVI 患者与单独 PFI 患者之间的差异最大(HR 4.01,p=0.029)。

结论

这些结果强调了根据 FI 和 RVI 的位置对 pT3a RCC 进行细分,以便对患者进行分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6099/8510928/5da37a8fd726/345_2021_3638_Fig1a_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验